HMedical ResearchEIN: 812849764· Ruling Year: 2016

Glioblastoma Foundation Inc

Durham, North Carolina

A-Health Score
77A-

Financial Health Score

9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.

Very Good

💰
$1.5M
Total Revenue
📊
$854K
Total Expenses
🏦
$1.8M
Net Assets
📋
N/A
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+17.4%
Year-over-year change (2021 → 2022)
Net Margin
+42.0%
Revenue minus expenses as % of revenue

Filing History

7 filings on record
YearRevenueExpensesAssets
2022$1,471,55017%$853,57821%$1,781,39917%
2021$1,253,57431%$703,351117%$1,523,93634%
2020$958,672114%$323,9289%$1,140,681150%
2019$448,67743%$296,591500%$455,94050%
2018$313,448548%$49,459435%$303,854662%
2017$48,380312%$9,25316%$39,8655302%
2016$11,749$11,011$738

Frequently Asked Questions

What does Glioblastoma Foundation Inc do?

Glioblastoma Foundation Inc is a medical research nonprofit organization based in North Carolina. It is classified under NTEE code H30 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Glioblastoma Foundation Inc financially healthy?

Based on our 9-metric Financial Health Score model, Glioblastoma Foundation Inc has a score of 77/100 (Grade: A-). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.

How much revenue does Glioblastoma Foundation Inc generate?

Glioblastoma Foundation Inc reports $2.1M in annual revenue and holds $3.7M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in North Carolina.